Zobrazeno 1 - 10
of 613
pro vyhledávání: '"DEXAMETHASONE"'
Autor:
Bumma N; James Cancer Center, Ohio State Medical Center, Columbus, Ohio, USA., Dhakal B; Bone Marrow Transplant and Cellular Therapy Program, Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Fraser R; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Estrada-Merly N; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Anderson K; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Freytes CO; Bone Marrow Transplant Program, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA., Hildebrandt GC; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA., Holmberg L; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Krem MM; Division of Hematology/BMT, Kansas City Veterans Affairs Medical Center, Kansas City, Missouri, USA., Lee C; Department of Hematology, Royal Adelaide Hospital, Adelaide, South Australia, Australia., Lekakis L; Division of Transplantation and Cellular Therapy, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami, Florida, USA., Lazarus HM; University Hospital Seidman Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA., Mian H; Department of Oncology, McMaster University, Hamilton, Ontario, Canada., Murthy HS; Blood and Marrow Transplantation Program, Division of Hematology-Oncology, Mayo Clinic, Jacksonville, Florida, USA., Nathan S; Section of Bone Marrow Transplant and Cell Therapy, Division of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, Illinois, USA., Nishihori T; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Parrondo R; Blood and Marrow Transplantation Program, Division of Hematology-Oncology, Mayo Clinic, Jacksonville, Florida, USA., Patel SS; Transplant and Cellular Therapy Program, Huntsman Cancer Center Institute, University of Utah, Salt Lake City, Utah, USA., Solh M; The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, Georgia, USA., Strouse C; Division of Hematology, Oncology, and Bone Marrow Transplantation, University of Iowa, Iowa City, Iowa, USA., Vesole DH; Jonn Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, USA., Kumar S; Hematology/Oncology, Mayo Clinic, Rochester, Minnesota, USA., Qazilbash MH; Department of Blood and Marrow Transplantation, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Shah N; Division of Hematology-Oncology, University of California San Francisco, San Francisco, California, USA., D'Souza A; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Sidana S; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford Health Care, Stanford, California, USA.
Publikováno v:
Cancer [Cancer] 2023 Jul 15; Vol. 129 (14), pp. 2179-2191. Date of Electronic Publication: 2023 Apr 06.
Autor:
Borthakur G; The University of Texas MD Anderson Cancer Center, Houston, Texas., Martinelli G; Department of Specialized, Diagnostic, and Experimental Medicine, University of Bologna, Bologna, Italy., Raffoux E; Saint Louis Hospital, Paris, France., Chevallier P; Central University Research Hospital (CHRU) De Nantes, Hotel-Dieu, Nantes, France., Chromik J; University Hospital Frankfurt, Frankfurt am Main, Germany., Lithio A; Eli Lilly and Company, Indianapolis, Indiana., Smith CL; Eli Lilly and Company, Surrey, United Kingdom., Yuen E; Eli Lilly and Company, Surrey, United Kingdom., Oakley GJ 3rd; Eli Lilly and Company, Indianapolis, Indiana., Benhadji KA; Eli Lilly and Company, Indianapolis, Indiana., DeAngelo DJ; Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Cancer [Cancer] 2021 Feb 01; Vol. 127 (3), pp. 372-380. Date of Electronic Publication: 2020 Oct 27.
Autor:
Dimopoulos MA; National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Lonial S; Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia., Betts KA; Analysis Group, Inc, Boston, Massachusetts., Chen C; Bristol-Myers Squibb, Princeton, New Jersey., Zichlin ML; Analysis Group, Inc, Boston, Massachusetts., Brun A; Bristol-Myers Squibb, Princeton, New Jersey., Signorovitch JE; Analysis Group, Inc, Boston, Massachusetts., Makenbaeva D; Bristol-Myers Squibb, Princeton, New Jersey., Mekan S; Bristol-Myers Squibb, Princeton, New Jersey., Sy O; Bristol-Myers Squibb, Princeton, New Jersey., Weisel K; University of Tübingen, Tübingen, Germany., Richardson PG; Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Cancer [Cancer] 2018 Oct 15; Vol. 124 (20), pp. 4032-4043. Date of Electronic Publication: 2018 Sep 11.
Autor:
Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Huang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Khouri M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Burger J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Khoury J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jorgensen J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Cortes J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jacob J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Montalbano K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Garris R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., O'Brien S; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, California., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Cancer [Cancer] 2018 Oct 15; Vol. 124 (20), pp. 4044-4055. Date of Electronic Publication: 2018 Oct 11.
Autor:
Matsuura K; Department of Breast Oncology, Saitama Medical University International Medical Center, Saitama, Japan., Tsurutani J; Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japan., Inoue K; Department of Breast Oncology, Saitama Cancer Center, Saitama, Japan., Tanabe Y; Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan., Taira T; Department of Medical Oncology, Sagara Hospital, Kagoshima, Japan., Kubota K; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan., Tamura T; Thoracic Center, St. Luke's International Hospital, Tokyo, Japan., Saeki T; Department of Breast Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
Publikováno v:
Cancer [Cancer] 2022 Apr 15; Vol. 128 (8), pp. 1692-1698. Date of Electronic Publication: 2022 Jan 19.
Autor:
Morita K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Montalban Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Cortes JE; Department of Medicine, Medical College of Georgia, Augusta, Georgia.; Georgia Cancer Center, Augusta, Georgia., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Cancer [Cancer] 2021 Aug 01; Vol. 127 (15), pp. 2641-2647. Date of Electronic Publication: 2021 Apr 06.
Autor:
Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Morita K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Khoury JD; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jorgensen JL; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Khouri IF; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Schroeder HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Khouri M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Garris R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., O'Brien SM; Division of Hematology/Oncology, Department of Medicine, UCI Health, Orange, California., Jabbour EJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Cancer [Cancer] 2021 Sep 15; Vol. 127 (18), pp. 3381-3389. Date of Electronic Publication: 2021 Jun 17.
Autor:
Gay F; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Torino, Italy., Günther A; Division of Stem Cell Transplantation and Immunotherapy, University of Kiel, Kiel, Germany., Offidani M; Hematology Clinic, AOU Ospedali Riuniti di Ancona, Ancona, Italy., Engelhardt M; Department for Hematology and Oncology, University of Freiburg, Faculty of Freiburg, Freiburg, Germany., Salvini M; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Torino, Italy., Montefusco V; Hematology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Patriarca F; Hematology and Transplant Unit, University of Udine, Udine, Italy., Aquino S; Ematologia e Centro Trapianti, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Pönisch W; Department of Hematology, University of Leipzig, Leipzig, Germany., Spada S; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Torino, Italy., Schub N; Division of Stem Cell Transplantation and Immunotherapy, University of Kiel, Kiel, Germany., Gentili S; UODS Ematologia AV3, Civitanova Marche, Italy., Wäsch R; Department for Hematology and Oncology, University of Freiburg, Faculty of Freiburg, Freiburg, Germany., Corradini P; Hematology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Straka C; Department of Hematology and Oncology, Munich Clinic Schwabing, Munich, Germany., Palumbo A; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Torino, Italy., Einsele H; Department of Medicine II, University Hospital of Würzburg, Würzburg, Germany., Boccadoro M; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Torino, Italy., Sonneveld P; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands., Gramatzki M; Division of Stem Cell Transplantation and Immunotherapy, University of Kiel, Kiel, Germany.
Publikováno v:
Cancer [Cancer] 2021 Sep 15; Vol. 127 (18), pp. 3413-3421. Date of Electronic Publication: 2021 Jun 28.
Autor:
Jeha S; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Crews KR; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee., Pei D; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee., Peyton M; Cancer Center Administration, St. Jude Children's Research Hospital, Memphis, Tennessee., Panetta JC; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee., Ribeiro RC; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Zhao X; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee., Campbell P; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Metzger ML; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Yang JJ; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee., Cheng C; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee., Pui CH; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Bhojwani D; Children's Hospital Los Angeles, Los Angeles, California.; Keck School of Medicine, University of Southern California, Los Angeles, California.
Publikováno v:
Cancer [Cancer] 2021 Jun 15; Vol. 127 (12), pp. 2074-2082. Date of Electronic Publication: 2021 Feb 17.
Autor:
Printz C
Publikováno v:
Cancer [Cancer] 2021 Feb 01; Vol. 127 (3), pp. 333.